✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic MigraineChronic PainNeurologyThcQuality Of Life Why This MattersMigraine affects over 1 billion people globally...
Clinical Outcomes and Patient Profiles in the UK Medical Cannabis Registry: A k-Means Clustering Analysis.
There is a paucity of high-quality evidence on the clinical efficacy of cannabis-based medicinal products (CBMPs). The objective of this study was to perform…
Effect of Cannabigerol on Sleep and Quality of Life in Veterans: A Decentralized, Randomized, Placebo-Controlled Trial.
This decentralized, randomized, triple-blind, placebo-controlled study evaluated efficacy and safety of oral cannabigerol (CBG) in Veterans with sleep issues…
Real-Time and Long-Term Effects of Medical Marijuana on Older Adults: Protocol for a Prospective Cohort Study.
Older adults represent the fastest-growing group of medical marijuana (MM) users in the United States, with chronic pain being the most common reason for use…
Corticobasal Degeneration | Pacific Neuroscience Institute
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Neurodegenerative DiseaseMovement DisordersPalliative CareNeuroprotectionQuality Of Life Why This MattersCorticobasal degeneration (CBD) represents a rare...
Health-related quality of life in patients receiving medicinal cannabis: systematic review and meta-analysis of primary research findings 2015-2025.
The global burden of chronic health conditions is significant. Medicinal cannabis (MC) is a legalised treatment option for patients with chronic health condi…
Effort to allow more employers to fire medical marijuana users – YouTube
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicySafetyIndustry Why This Matters Employment protections for medical cannabis users directly affect patient access and...
No ‘next day’ impairment caused by cannabis – The Leaf Online
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchSafetyAging Dr. Caplan's Take "What this research tells us clinically is that we can now...
Ohio cannabis recall issued after product failed to meet testing requirements
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. SafetyPolicyIndustry Why This Matters A recall of cannabis products that failed testing requirements highlights the...
Marijuana gummies sold in Ohio recalled. Why, where they were sold – The Columbus Dispatch
✦ New CED Clinical Relevance #95 Landmark Clinical Evidence Peer-reviewed human research with direct implications for cannabis medicine practice. SafetyPolicyIndustry Why This Matters I don't see a summary provided for this article....